subscribeSubscribe
price-trendAsk Us
Laekna doses first subject in Phase I/II prostate cancer trial

Laekna doses first subject in Phase I/II prostate cancer trial
CLINICALTRIALSARENA
06 Sep 2022
Share Share
Innovent and Laekna begin Dosing with Three-drug Combination in PI/II Study

Innovent and Laekna begin Dosing with Three-drug Combination in PI/II Study
PRNEWSWIRE
31 Jul 2022
Share Share
Laekna doses first subjects in Phase Ib/III breast cancer therapy trial

Laekna doses first subjects in Phase Ib/III breast cancer therapy trial
CLINICALTRIALSARENA
27 May 2022
Share Share
Laekna Therapeutics Begins Dosing in PIb/III Study of Afuresertib + Fulvestrant

Laekna Therapeutics Begins Dosing in PIb/III Study of Afuresertib + Fulvestrant
PRNEWSWIRE
26 May 2022
Share Share
Novartis farms out rare disease drug to LifeMax Labs

Novartis farms out rare disease drug to LifeMax Labs
Amirah Al Idrus FIERCE BIOTECH
28 Aug 2018
Share Share